Preliminary Program
Session times on those days will not be finalized until the overall program schedule is completed.
Program Tracks (Please click each Track for detailed program information) |
Track 2: Breakthroughs in Cancer Prognostics and Diagnostics |
Track 1: Recent Advances in Cancer Research
Track 1-1: Cancer Molecular Biology
Time: May 15, 2019 (Wednesday) |
|
Chair |
Dr. Ying Chen, Professor, Chengdu Women's and Children's Central Hospital, Chin |
13:30-13:35 |
Chair's Introduction |
13:35-13:55 |
Title: Development of an Orally-Administered Peptide Vaccine against KRAS Positive Cancers Using a Double-Coated Live Delivery Vector Approach |
13:55-14:15 |
Title: Association of Familial Hodgkin Lymphoma with Deficiency of Adenosine Deaminase 2 (DADA2) |
14:15-14:35 |
Title: Identification and Characterization of Novel Tumor Cell Cycle Regulators Using shRNA Expression Vector Library |
14:35-14:55 | Title: MiRNA Pain of Endometriosis Dr. Ying Chen, Professor, Chengdu Women's and Children's Central Hospital, China |
14:55-15:15 | Title: IL-33 Promotes Tumor Growth and Metastasis by Remodeling the Tumor Microenvironment Dr. Maria Marjorette O. Pena, Associate Professor & Director, Mouse Experimentation Core - Center for Colon Cancer Research, University of South Carolina, USA |
15:15-15:30 |
Coffee Break |
15:30-15:50 | Title: Anesthesia and Cancer Metastasis Dr. Rick Sai-Chuen Wu, Professor, China Medical University, Taiwan |
15:50-16:10 |
Title: Down-Regulation of A20 in the Tumor Microenvironment Suppresses Tumor Growth by Inducing MDSC Apoptosis and Blocking Protumor Macrophage Polarization |
16:10-16:30 |
Title: Cytotoxic Anticancer Activity of Graphene Oxide-Associated Therapeutic Antibodies |
16:30-16:50 |
Title: Saponin from Tupistra Chinensis Bak Inhibits NF-κB Signaling in Sarcoma S-180 Cell Mouse Xenografts |
Track 1-2: Cancer Cell Biology
Time: May 16, 2019 (Thursday) |
|
Chair |
Dr. Adolfo Cavalié, Professor, Experimental and Clinical Pharmacology and Toxicology, Saarland University, Germany |
Co-Chair | Dr. Sen-Yung Hsieh, Professor & Chair, Chang Gung Memorial Hospital, Taiwan |
09:00-09:05 |
Chair's Introduction |
09:05-09:25 |
Title: Feedback Control of the Estrogen-Chemokine Axis in Reproductive Cancers |
09:25-09:45 |
Title: Sec61-Mediated Calcium Depletion in The Endoplasmic Reticulum of Cancer Cells |
09:45-10:05 |
Title: RGD-Targeted Ultrasound Contrast Agent for Longitudinal Assessment of Hep-2 Tumor Angiogenesis in vivo |
10:05-10:25 |
Title: Molecular Basis of Anti-Cancer Effect of Huaier and Specific Influence to the Natural Selection of iPS Cells and Stable Growth in vivo |
10:25-10:45 |
Title: Turtle Shell Inhibits Angiogenesis by Down-Regulating Glycolysis/Gluconeogenesis Signaling in Zebrafish |
10:45-11:00 |
Coffee Break |
11:00-11:20 |
Title: Actin Cytoskeleton Remodeling-Induced Epithelial-Mesenchymal Transition: A Mechanistic Link of Large Tumors with Invasion/Metastasis |
11:20-11:40 |
Title: Tumour-Suppressive and Tumour-Promoting Functions of Activin Signaling in Melanoma |
11:40-12:00 |
Title: The Short and Long Term Efficacy and Safety of Completely Anatomic Thoracoscopic Segmentectomy in the Treatment of Solitary Pulmonary Nodules |
12:00-12:20 |
Title: From Autophagy to Autosis - Reprogramming of Cancer Cell Metabolism, as a Tool for Tumor Eradication |
BIT Group Global Ltd.
Japan-China Business Co., Ltd.
日中商務株式会社
Dr. Vladimir Lazar
Chief Scientific and Operating Officer
WIN Consortium, France
Dr. Ashok Srivastava
Chief Executive Officer & Chief Medical Officer, ClinFomatrix, Cure Pharmaceuticals, Inc, USA
Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China]
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2008-2019 BIT Congress Inc.